Exploratory randomized trial of evaluation for Tiotropium in lung cancer surgery
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2019
Price : $35 *
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Postoperative complications
- Focus Pharmacodynamics
- 11 Nov 2019 Planned End Date changed from 31 Mar 2018 to 31 Oct 2019.
- 10 May 2018 Status changed from suspended to active, no longer recruiting.
- 07 Nov 2016 Status changed from recruiting to suspended.